Gaorong Ventures

Venture capital firm

Value Add VC tracks 3 companies Gaorong Ventures has invested in and 3 venture rounds it took part in (0 as lead).

Gaorong Ventures key facts (as of )

FactValueSource
TypeVenture capital firmValue Add VC classification
Venture rounds tracked3 (led 0, joined 3)
3 in the last 12 months
Recent deals table on this page (each round cites its source)
Portfolio companies tracked3Portfolio list on this page

Recent deals we track

3

Track record: led 0 and participated in 3 of 3 tracked venture rounds · 3 in the last 12 months

DateCompanyEventRoleAmountValuationInvestorsSource
Sep 16, 2026Anew Labsfunding roundParticipated$290M$1.5B
HongShan (Sequoia China)LeadIDG CapitalHillhouseGaorong VenturesPrimavera CapitalBoyu Capitalunverified5Y CapitalShanghai Future Industries FundSBP Group
TheNextWeb
Sep 8, 2026Moonwalk BiosciencesSeries BParticipated$70M—BioSpace
Aug 24, 2026Xpeng Roboticsfunding roundParticipated$900M$6.3BElectrek

Is something wrong on this page?

We track Gaorong Ventures but have little verified detail yet.

At a glance

Gaorong Ventures appears in 3 funding rounds tracked by ValueAddVC since 2026. Its most frequent sector in these rounds is Health & Biotech, and its most recent tracked deal was Anew Labs' $290M round (Sep 16, 2026). It co-invests most often with IDG Capital.

Portfolio

3 total

Sector / Stage Activity

By sector (portfolio)
Biotech
2 · 67%
Robotics
1 · 33%

Co-Investors

10

Value Add Research

Latest Pulse

  1. Pragmatik Labs Hits A Reported $5B Valuation | 2.5x Its $2B August MarkPragmatik Labs, the Shanghai agent lab founded by former Alibaba Qwen lead Lin Junyang, reportedly closed a round of tens of millions of dollars at a $5 billion valuation, up from $2 billion in August.→
  2. Moonwalk Biosciences Raises $70M For Obesity RNAiMoonwalk Biosciences closed an oversubscribed $70 million Series B to advance an adipose-targeted RNA interference therapy for obesity toward its first human trial, bringing total funding to roughly $127 million since its 2024 launch.→
  3. XPeng's Robotics Unit Raises $900M at $6.3B ValueXPeng Robotics raised over $900 million in its first external funding round, valuing the humanoid-robot unit at more than $6.3 billion, backed by IDG Capital, Alibaba and Tencent ahead of planned IRON robot mass production by year-end.→
  4. XPeng Robotics Raises $900M+ at $6.3B ValuationXPeng's robotics unit raised more than $900 million at a $6.3 billion post-money valuation, the largest single-round private raise in China's embodied-AI industry, led by IDG Capital with Tencent and Alibaba as strategic backers.→

Gaorong Ventures FAQ

What stage does Gaorong Ventures invest at?

In the rounds Value Add VC tracks, Gaorong Ventures' deals were most often Series B (1).

What companies has Gaorong Ventures backed?

Companies Value Add VC tracks as Gaorong Ventures investments include Anew Labs, Moonwalk Biosciences and Xpeng Robotics.

Who does Gaorong Ventures co-invest with most?

In the rounds Value Add tracks, Gaorong Ventures most often invests alongside IDG Capital (2 shared deals), Alibaba (1 shared deal), Alpha Wave Global (1 shared deal), ARCH Venture Partners (1 shared deal), Eli Lilly and Company (1 shared deal).

Sources & methodologyshow
Where these figures come from

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data ·